-The Guardian The global application of a fraudulent economic theory brought the west to its knees. Yet for those in power, it offers riches How they must bleed for us. In 2012, the world's 100 richest people became $241 billion richer. They are now worth $1.9 trillion: just a little less than the entire output of the United Kingdom. This is not the result of chance. The rise in the fortunes of the...
More »SEARCH RESULT
Have government schemes failed Muslims?-Subodh Varma
-The Times of India Six years ago, the Sachar Committee reportshowed that the Muslim community in India suffers from severe deprivations in education, employment, health services, public infrastructure, access to financial services leading to much higher poverty than other religious groups, somewhat like the condition of scheduled castes and tribes. The government responded by setting up a separate ministry for minority affairs, and launching several programs to provide benefits to the...
More »A woman-shaped gap in the Indian workforce-Jayan Jose Thomas
-The Hindu A mix of social constraints and dearth of employment opportunities has kept women out of the labour market, leading to a huge opportunity cost to the nation Women in India face enormous challenges for their participation in the economy — in a way that mirrors the many injustices they suffer in the society at large. The labour participation rate of women — that is, the number of women in the...
More »Understanding FDI in Retail: What Can Economic Principles Teach Us? -Abhirup Sarkar
-Economic and Political Weekly The recent debate on the acceptability of foreign direct investment in the retail sector in India has been mostly political. It is necessary to look into the pros and cons of FDI in retail from a purely economic point of view. This article identifi es the safeguards that should be undertaken before allowing giant multinationals to function in the country. Abhirup Sarkar (abhirup@isical.ac.in) is with the Indian Statistical...
More »Clinical trial relief norms flawed -Rema Nagarajan
-The Times of India The new Central Drug Standards Control Organisation (CDSCO) guidelines meant to help calculate compensation in case of clinical trial related injury or death in a fair and equitable manner seem to be loaded against the very people it is meant to help. The guidelines suggest a formula based on the income of the injured or dead person along with age and severity of disease. Such a formula raises...
More »